New drug candidate shows promise in overcoming chemotherapy resistance in small cell lung cancer (opens in new tab)

A research team led by Prof. Liu Qingsong at the Institute of Health and Medical Technology, the Hefei Institutes of Physical Science of the Chinese Academy of Sciences has discovered a new drug candidate that may help overcome chemotherapy resistance in small cell lung cancer (SCLC). The study, published in Signal Transduction and Targeted Therapy, introduces a compound called IHMT-15137, which works by blocking a key signaling pathway linked to drug resistance.